Cargando…

Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease

BACKGROUND: The esophageal intraluminal baseline impedance may be used to evaluate the status of mucosa integrity. Esophageal acid exposure decreases the baseline impedance. We aimed to compare baseline impedance in patients with various reflux events and with different acid-related parameters, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Chanjuan, Duan, Liping, Wang, Kun, Xu, Zhijie, Ge, Ying, Yang, Changqing, Han, Yajing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2012
Materias:	Original Article—Alimentary Tract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654188/ https://www.ncbi.nlm.nih.gov/pubmed/23076541 http://dx.doi.org/10.1007/s00535-012-0689-6

Ejemplares similares

The Role of Gastroesophageal Reflux in Provoking High Blood Pressure Episodes in Patients With Hypertension
por: Li, Zhi-tong, et al.
Publicado: (2018)

Supragastric belching in Japan: lower prevalence and relevance for management of gastroesophageal reflux disease compared to United Kingdom
por: Sawada, Akinari, et al.
Publicado: (2020)

Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease
por: Miwa, Hiroto, et al.
Publicado: (2019)

Post-reflux swallow-induced peristaltic wave (PSPW): physiology, triggering factors and role in reflux clearance in healthy subjects
por: Zhang, Mengyu, et al.
Publicado: (2020)

A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis
por: Nagahara, Akihito, et al.
Publicado: (2013)

Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2017)

Esophageal Bolus Transit in Newborns with Gastroesophageal Reflux Disease Symptoms: A Multichannel Intraluminal Impedance Study
por: Cresi, Francesco, et al.
Publicado: (2015)

Comparison of multichannel intraluminal impedance-pH monitoring and reflux scintigraphy in pediatric patients with suspected gastroesophageal reflux
por: Uslu Kızılkan, Nuray, et al.
Publicado: (2016)

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease()()
por: Jabri*, ‡, §, Bana, et al.
Publicado: (2000)

Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases
por: Zhang, Hu, et al.
Publicado: (2020)

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine
por: Siniscalchi, Monica, et al.
Publicado: (2020)

Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey
por: Marasco, Giovanni, et al.
Publicado: (2020)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
por: Maconi, Giovanni, et al.
Publicado: (2021)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
por: Elli, Luca, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group
por: Arrigo, Serena, et al.
Publicado: (2021)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

Mean nocturnal baseline impedance, a novel metric of multichannel intraluminal impedance-pH monitoring in diagnosing gastroesophageal reflux disease
por: Wu, Yanhong, et al.
Publicado: (2022)

The Relationship of the Post-reflux Swallow-induced Peristaltic Wave Index and Esophageal Baseline Impedance with Gastroesophageal Reflux Disease Symptoms
por: Cho, Young Kyu, et al.
Publicado: (2017)

Multichannel intraluminal impedance-pH and psychometric properties in gastroesophageal reflux: systematic review()
por: Gonçalves, Emília Silva, et al.
Publicado: (2020)

Patients with dyspepsia have impaired mucosal integrity both in the duodenum and jejunum: in vivo assessment of small bowel mucosal integrity using baseline impedance
por: Nakagawa, Kenichiro, et al.
Publicado: (2019)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Baseline impedance via manometry and ambulatory reflux testing are not equivalent when utilized in the evaluation of potential extra-esophageal gastroesophageal reflux disease
por: Zikos, Thomas A., et al.
Publicado: (2020)

Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease
por: Ye, Bi Xing, et al.
Publicado: (2017)

Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors
por: Jiang, Liuqin, et al.
Publicado: (2016)

Diagnostic accuracy of multichannel intraluminal impedance-pH monitoring for gastroesophageal reflux-induced chronic cough
por: Li, Na, et al.
Publicado: (2021)

Multichannel Intraluminal Impedance and pH Monitoring are Complementary Methods in the Diagnosis of Gastroesophageal Reflux Disease in Children
por: Altay, Derya, et al.
Publicado: (2022)

Local inflammatory response to gastroesophageal reflux: Association of gene expression of inflammatory cytokines with esophageal multichannel intraluminal impedance-pH data
por: Morozov, Sergey, et al.
Publicado: (2022)

Combined multi-channel intraluminal impedance measurement and pHmetry in the detection of gastroesophageal reflux disease in children with cystic fibrosis
por: Gonçalves, Emília da Silva, et al.
Publicado: (2022)

Pre and post-operative evaluation of gastroesophageal reflux and esophageal motility in neurologically impaired children using combined pH–multichannel intraluminal impedance measurements
por: Fukahori, Suguru, et al.
Publicado: (2013)

Whether the Role of Esophageal Baseline Impedance Is Complementary to or Alternative to the 24-Hour Esophageal pH Monitoring for the Diagnosis of Gastroesophageal Reflux Disease?
por: Cho, Yu Kyung
Publicado: (2020)

Prevalence of gastroesophageal reflux disease in children with extraesophageal manifestations using combined-video, multichannel intraluminal impedance-pH study
por: Eiamkulbutr, Sutha, et al.
Publicado: (2023)

Profiling of circulating microRNAs in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Bus, Pauline, et al.
Publicado: (2015)

Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection
por: Hasnain, Sumaira Z., et al.
Publicado: (2010)

IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease
por: Tremelling, Mark, et al.
Publicado: (2007)

Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
por: Camargo, Simone M.R., et al.
Publicado: (2009)

Multicenter prospective in vivo study of an endocytoscope system (ECS) for superficial esophageal cancer
por: Morita, Shuko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10dsnfmgrqrh45ekedds9dth2m